Author - Mike Scialom

Cambridge-based AKU Society in BBC Radio 4 fundraising appeal

Nationwide callout will help treatments to start before onset of disease

Hire Turtle Dove’s van – it’s a good cause – for £60 a day

Hire Turtle Dove’s van – it’s a good cause – for £60 a day

Social enterprise supports young women through vulnerable times

Regulatory Genome Project offers clarity on financial regulations worldwide

25 April 2021

Regulatory Genome Project offers clarity on financial regulations worldwide

25 April 2021

Dr Robert Wardrop on how machine learning is bringing clarity to global economic rules

Movement Against Racism and Green New Deal campaigners take to Cambridge streets

24 April 2021

Movement Against Racism and Green New Deal campaigners take to Cambridge streets

24 April 2021

Good-natured day of activism as crowds fill city centre

Cambridge City Council frustrated as Cambridgeshire Pension Fund refuses to divest £57m in fossil fuels

Cambridge City Council frustrated as Cambridgeshire Pension Fund refuses to divest £57m in fossil fuels

But Cllr Richard Robertson pledges to keep up the pressure.

Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Phico Therapeutics awarded £13.2m by CARB-X accelerator to fight anti-bacterial resistance

Its lead product can target bacteria in the lungs without damaging other cells.

GetMeFit duo launch fitness class platform to match instructors with public

GetMeFit duo launch fitness class platform to match instructors with public

‘Booking system and discovery platform’ developed by duo based in Barley

Jesus Green mast plans quashed: Bridge House alternative approved - but Lib Dems say ‘trust in council shaken’

Jesus Green mast plans quashed: Bridge House alternative approved - but Lib Dems say ‘trust in council shaken’

Prospect of 30m structure on Jesus Green is formally abandoned.

Alchemab Therapeutics raises £60m in ‘elite’ Series A backing

Alchemab Therapeutics raises £60m in ‘elite’ Series A backing

Babraham Research Campus company identifies naturally protective antibodies with therapeutic potential

Jesus College climate group adds racial justice and animal agriculture to divestment demands

21 April 2021

Jesus College climate group adds racial justice and animal agriculture to divestment demands

21 April 2021

Cambridge University college responds, saying: ‘We recognise the urgency of climate change’

Money Rebellion continues as Extinction Rebellion target Cambridge’s banks

Money Rebellion continues as Extinction Rebellion target Cambridge’s banks

Red Rebels join performers and activists as banks pour trillions into fossil fuel entities

Cyted’s Marcel Gehrung in Forbes’ ‘30 Under 30’ list

Cyted’s Marcel Gehrung in Forbes’ ‘30 Under 30’ list

Co-founder and CEO of digital detection of disease specialist

Moss & Rose ready for start of a vintage pop-up summer

Moss & Rose ready for start of a vintage pop-up summer

Clothing and accessories range is taken by caravan to festivals and events

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

It will receive $20m upfront.

Ever Resource promises ‘circular economy of materials for battery market’

Ever Resource promises ‘circular economy of materials for battery market’

£995,000 Innovate UK grant for lithium recycling project

Triumph for Cambridge urban winery as Bacchus 2020 goes on sale May 3

15 April 2021

Triumph for Cambridge urban winery as Bacchus 2020 goes on sale May 3

15 April 2021

Chesterton-based Gutter & Stars begins musical grape journey with ‘I Wanna Be Adored’

More modular homes being built to tackle Cambridge homelessness

10 April 2021

More modular homes being built to tackle Cambridge homelessness

10 April 2021

Allia appeals for funding from city firms to make up shortfall

IONTAS relocates to The Works

IONTAS relocates to The Works

Unity Campus showcase for outsourced antibody discovery services company

Eliem Therapeutics is out of stealth mode and $80m in the black

Eliem Therapeutics is out of stealth mode and $80m in the black